X6T-19794-02991 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-02
Dose 1 — Pfizer-BioNTech
2021-01-22
Dose 2 — Pfizer-BioNTech
2021-01-23
Registered in v-safe
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-23
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-07-24
Survey response — 6 months, dose 2
MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school

Free text: URI symptoms

MedDRA releases: 2021-09,2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-02	Pfizer-BioNTech
2	2021-01-22	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-23	priority 2/3

Free text

Release 9 — 6 months, dose 2

2021-07-24

Symptoms: URI symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Upper respiratory tract infection	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release